A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury.

@article{Almalki2017APR,
  title={A pragmatic randomized controlled trial comparing pathway-based versus usual care in community-acquired acute kidney injury.},
  author={Abdullah Almalki and Sherine Ismail and Mohammad Amir Qureshi and Zuhair Abunijem and M. A. Mustafa El Balla and Saliman Karsou and Rehan A Qureshi and Akram Neyaz Ahmad and Salhah S Alsulami and Maryam Khalil and Jani Hafez and Jane E H Thomson and Muhammad Ali Siddiqui and Oyindamola Bidemi Yusuf and Zeyad A Zahrani and Abdulhameed Gasim and K H Mujtaba Quadri},
  journal={Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia},
  year={2017},
  volume={28 6},
  pages={
          1282-1292
        }
}
Clinical pathways have shown conflicting evidence in improvement of several patient-centered outcomes across different clinical settings. However, the effectiveness of clinical pathway in management of acute kidney injury (AKI) has not been reported. Therefore, we aimed to assess the length of hospital stay (LOS) and patient-centered outcomes in community acquired AKI and compared pathway care (PC) versus usual care (UC). The CHAMP-Path AKI Trial is a pragmatic, parallel, single-blind… CONTINUE READING
Highly Cited
This paper has 18 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations